PET/CT Imaging of Angiogenesis in Patients With Neuroendocrine Tumors Using 68Ga-NODAGA-E[c(RGDyK)]2
NCT03271281
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
113
Enrollment
OTHER
Sponsor class
Conditions
Neuroendocrine Tumors
Interventions
DRUG:
One injection of 68Ga-NODAGA-E[c(RGDyK)]2
DEVICE:
PET/CT
Sponsor
Rigshospitalet, Denmark